// App-Quantinova.ai

: DOES THE PRESENCE OF CLASSIC AND NOVEL ANTIPHOSPHOLIPID ANTIBODIES INFLUENCE THE RISK OF THROMBOSIS DEVELOPMENT IN PATIENTS WITH UTERINE MALIGNANCIES?

Researchers

Presenter

  • Andrzej Majdan

Principal Investigators

  • Magdalena Dryglewska

  • Jan Kotarski

  • Maria Majdan

Medical Centers

  • Medical University of Lublin, Dept of Gynaecological Oncology and Gynecology, Lublin, Poland

  • Medical University of Lublin, Rheumatology and Connective Tissue Diseases, Lublin, Poland

  • Medical University of Lublin, Rheumatology and Connective Tissue Diseases, Lublin, Poland

Locations

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • Phosphatidylinositol

  • LT 02

  • Phosphatidylserine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved